1. AB0460 Glpg0634, A Selective JAK1 Inhibitor, Confirms Its Low Liability for Drug-Drug Interactions. (10th June 2014) Authors: Namour, F.; Desrivot, J.; Tasset, C.; Van der Aa, A.; van't Klooster, G. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 960 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0494 Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, Shows Similar PK and PD Profiles in Japanese and Caucasian Healthy Volunteers. (9th June 2015) Authors: Namour, F.; Vayssière, B.; Galien, R.; Fagard, L.; Van der Aa, A.; Harrison, P.; Tasset, C. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1063 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparison of cytokine gene polymorphism in drug‐induced maculopapular eruption, urticaria and drug reaction with eosinophilia and systemic symptoms (DRESS). (6th March 2013) Authors: Barbaud, A.; Waton, J.; Herbeth, B.; Bursztejn, A.C.; Bollaert, M.; Schmutz, J.L.; Guéant‐Rodriguez, R.M.; Namour, F.; Guéant, J.L.; Aimone‐Gastin, I. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 28:Number 4(2014:Apr.) Page Start: 491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0263 Efficacy and safety of GLPG0634, a selective JAK1 inhibitor, after short-term treatment of rheumatoid arthritis; results of a phase IIA trial. (23rd January 2014) Authors: Vanhoutte, F.P.; Mazur, M.; Namour, F.; van der Aa, A.; Wigerinck, P.; van 't Klooster, G.A.E. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0123 Dose Selection of GLPG0634, a Selective JAK1 Inhibitor, for Rheumatoid Arthritis Phase 2B Studies: PK/PD and Exposure-DAS28 Modeling Approach. (10th June 2014) Authors: Namour, F.; Tasset, C.; van't Klooster, G.; Diderichsen, P.M.; Cox, E. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0236 Once-Daily Dosing of GLPG0634, a Selective JAK1 Inhibitor, is Supported by Its Active Metabolite. (23rd January 2014) Authors: Namour, F.; Galien, R.; Vanhoutte, F. P.; Wigerinck, P.; van 't Klooster, G. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗